However, Kington concedes, the agency may see a rise in grant applications beginning in 2011 if the stimulus money works as hoped to foster new discoveries and accelerate research. If that happens, he says, "we believe the success rate may drop at least several points from what it has been if we don't have a substantial increase in our budget".
Republicans on the subcommittee seemed sceptical that the stimulus funding would be spent on the best science. "Give us some confidence that, one, this will stimulate the economy as intended and, two, that you are not just going to be throwing money at new projects that hadn't made the [fundable] list before, " said Dennis Rehberg (Republican, Montana). The agency is revisiting 14,000 grant applications already in the NIH's pipeline that were judged to be scientifically meritorious but that were not funded in its last round of reviews. These may now receive funding if they can show potential to make progress within two years.
Kington defended those applications, calling the projects at "the top, right below our funding level". As for job creation, he says, the biomedical agency has estimated that each of its grants supports on average "six or seven jobs in part or in full". Pressed further by Rehberg, Kington said he would get back to him with the exact number of jobs to be created with the NIH's $10.4 billion. Few expect this to be an easy number to find (see page 563).
Also under fire at the same hearing was the National Children's Study, a project first authorized by Congress in 2000 that aims to follow environmental and genetic influences on the health of 105,000 children from the womb to the age of 21. During its planning phase, the Bush administration repeatedly tried to kill its funding, and Congress repeatedly restored it. This year, it is receiving $192 million -up from $111 million in 2008. Its seven 'vanguard' centres, conducting its pilot phase, will all be open and beginning to enrol patients this month.
But shifting numbers on its estimated cost have become a political pitfall. Several months ago, NIH officials called Todd Tiahrt, the subcommittee's senior Republican, to explain that the initial $3-billion-plus price tag on the study could end up being double that amount. Last week, Kington told Tiahrt that the agency had been estimating "a moving target" while the study was in the planning stages, and that when it became apparent that the study would cost more than originally expected, the NIH decided not to adjust the estimate upwards until the results of the pilot study were in. "That was an error in judgement, " Kington says. "We have every plan to bring the cost down. "
After the hearing, Duane Alexander, the director of the National Institute of Child Health and Human Development in Bethesda, Maryland, called the contention that the project's costs had doubled "a myth". During the pilot phase of the study, he says, "we have an attractive tree to hang ornaments on", referring to the lengthy list of subprojects encompassed by the pilot. "There was never any expectation or intent that we would be able to fund all that. "
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See also Party of One, page 563.
Congress probes NIH stimulus funds
The NIH must detail the economic benefits and number of new jobs it will create with stimulus monies.
The NIH received $10.4 billion in the US economic stimulus package. $7.4 billion of that will be used by individual institutes, much of it on grants already in the applications pipeline. The new pot of money many scientists are scrambling for is the $800 million granted to the director's office. Of this, roughly $291 million has been committed:
At least $200 million to Challenge Grants • Roughly $91 million to programmes • including Signature Initiatives, Core Centers for Enhancing Research Capacity in US Academic Institutions, and summer training programmes The remaining roughly $509 million will be committed later by the director, partly in Grand Opportunity Program grants.
SPENDING POWER NIH
Scrutiny also aimed at National Children's Study.
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